The Impact of COVID-19 is included in Intravenous Solution Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Intravenous Solution Trends and Forecast
The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Intravenous Solution by Segment
The study includes a forecast for the global intravenous solution by product, nutrients, and region.
Intravenous Solution Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition
Intravenous Solution Market by Nutrients [Shipment Analysis by Value from 2018 to 2030]:
• Carbohydrates
• Vitamins & Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others
Intravenous Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Intravenous Solution Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous solution companies profiled in this report include-
• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi
Intravenous Solution Market Insights
Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.
Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.
Features of the Global Intravenous Solution Market
Market Size Estimates: Intravenous solution market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Intravenous solution market size by product, nutrients, and region in terms of value ($B).
Regional Analysis: Intravenous solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, nutrients, and regions for the intravenous solution market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous solution market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the intravenous solution market size?
Answer: The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030.
Q2. What is the growth forecast for intravenous solution market?
Answer: The global intravenous solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the intravenous solution market?
Answer: The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.
Q4. What are the major segments for intravenous solution market?
Answer: The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets.
Q5. Who are the key intravenous solution market companies?
Answer: Some of the key intravenous solution companies are as follows:
• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi
Q6. Which intravenous solution market segment will be the largest in future?
Answer: Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.
Q7. In intravenous solution market, which region is expected to be the largest in next 5 years?
Answer: Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the intravenous solution market by product (total parenteral nutrition and peripheral parenteral nutrition), nutrients (carbohydrates, vitamins & minerals, single dose amino acids, parenteral lipid emulsion, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Intravenous Solution Market, Intravenous Solution Market Size, Intravenous Solution Market Growth, Intravenous Solution Market Analysis, Intravenous Solution Market Report, Intravenous Solution Market Share, Intravenous Solution Market Trends, Intravenous Solution Market Forecast, Intravenous Solution Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Intravenous Solution Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Intravenous Solution Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Intravenous Solution Market by Product
3.3.1: Total Parenteral Nutrition
3.3.2: Peripheral Parenteral Nutrition
3.4: Global Intravenous Solution Market by Nutrients
3.4.1: Carbohydrates
3.4.2: Vitamins & Minerals
3.4.3: Single Dose Amino Acids
3.4.4: Parenteral Lipid Emulsion
3.4.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Intravenous Solution Market by Region
4.2: North American Intravenous Solution Market
4.2.2: North American Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
4.3: European Intravenous Solution Market
4.3.1: European Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
4.3.2: European Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
4.4: APAC Intravenous Solution Market
4.4.1: APAC Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
4.4.2: APAC Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
4.5: ROW Intravenous Solution Market
4.5.1: ROW Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
4.5.2: ROW Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Intravenous Solution Market by Product
6.1.2: Growth Opportunities for the Global Intravenous Solution Market by Nutrients
6.1.3: Growth Opportunities for the Global Intravenous Solution Market by Region
6.2: Emerging Trends in the Global Intravenous Solution Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Intravenous Solution Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Solution Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Pfizer
7.2: Otsuka Pharmaceutical
7.3: Sichuan Kelun Pharmaceutical
7.4: Vifor Pharma Management
7.5: Grifols
7.6: Henry Schein
7.7: Soxa Formulations & Research
7.8: B. Braun Melsungen
7.9: Baxter International
7.10: Fresenius Kabi
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Intravenous Solution Market Report.